IMPAX Labs To Present At The Morgan Stanley Global Healthcare Conference

HAYWARD, Calif., Sept. 11, 2015 /PRNewswire/ -- Impax Laboratories, Inc.(NASDAQ: IPXL) invites investors and the general public to listen to a webcast of a discussion with Fred Wilkinson, President and CEO, and Bryan M. Reasons, Chief Financial Officer, at the Morgan Stanley Global Healthcare Conference on Friday, September 18, 2015 at 10:30 a.m. Eastern Time.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at www.impaxlabs.com. 

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Impax Generics division and markets its branded products through the Impax Specialty Pharma division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at: www.impaxlabs.com.

Company Contacts: 
Mark Donohue 
Investor Relations and Corporate Communications       
(215) 558-4526   
www.impaxlabs.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/impax-to-present-at-the-morgan-stanley-global-healthcare-conference-300141355.html

SOURCE Impax Laboratories, Inc.